Heartland Sneak Peek: HME Industry SWOT Analysis

Published in Government Relations on April 22, 2022

By Craig Douglas, Vice President, Payer and Member Relations, VGM Government Relations

The types and quantity of changes that have occurred within our industry over the past two years are unprecedented, and the majority of them have been driven by the COVID-19 pandemic. Some changes are legislative, some are regulatory, while others are payer policy/reimbursement related. Regardless of the type of change, they all impact your overall business strategy in some manner. These changes have made a profound impact on the DMEPOS industry as a whole, and most likely on your individual business as well. 

In the last 2 years, we’ve seen a Medicare competitive bid program that, for all intents and purposes, didn’t really happen for most of you, increased demand for certain products, policy changes from both CMS and private payers, reimbursement changes, supply chain issues, and product recalls that have impacted many DMEPOS providers.

From a cost perspective, several manufacturers have implemented either temporary surcharges or permanent price increases. These price increases are not limited to just a few manufacturers or a few products, but rather impact a large percentage of commonly requested DME product categories. In addition to the product cost changes, there have also been sharp increases in labor, shipping, fuel, and other overhead costs. There have also been new costs that weren’t there before, or that were previously minimal but are now much more substantial, such as PPE, temperature scanners, plastic barriers in the office, etc.

On the flip side of that, there have also been changes on the reimbursement side of things for many providers. Government program money (think Paycheck Protection Program, HHS Provider Relief Fund, etc.), as well as price increases from Medicare/Medicaid/private payers which helped offset some of the price increases providers were experiencing. Was there enough assistance? Was there too much? Many of those pricing changes are temporary, and there is still quite a bit of uncertainty surrounding the long-term reimbursement direction from the industry’s largest payer, CMS.

With all that has happened and that is yet to come, you may feel like you have more questions than answers in terms of what this looks like when ALL the dust settles.

Heartland LogoAt this year’s Heartland Conference, please join Craig Douglas, Ronda Buhrmester, Mark Higley, and John Gallagher from VGM as they discuss these topics, answer questions, and propose best practices and potential solutions to help your business thrive. Learn more and register at vgmheartland.com.   


TAGS

  1. billing & reimbursement
  2. cms
  3. heartland
  4. vgm government

From Our Experts

Deadline To Comment On CMS' Proposed Rule Is Today thumbnail Deadline To Comment On CMS' Proposed Rule Is Today VGM Group has submitted our comments on the CY26 CMS DMEPOS/Home Health Proposed Rule and encourages you to do the same (if you haven't done so already)!  Our comments provide key recommendations aimed at protecting patient access and supporting the HME community.  VGM's Key Recommendations Include: CONNECT for Health Act Gains Bipartisan Telehealth Support thumbnail CONNECT for Health Act Gains Bipartisan Telehealth Support On April 2, 2025, a bipartisan group of 60 senators reintroduced the CONNECT for Health Act, legislation that would expand patient access to telehealth services through Medicare while removing barriers to adoption. The bill would also make permanent the COVID-19 telehealth flexibilities currently set to expire Sept. 30. The lead sponsors of the bill are Sens. Brian Schatz (D-HI), Roger Wicker (R-MS), Mark Warner (D-VA), Cindy Hyde-Smith (R-MS), Peter Welch (D-VT), and John Barrasso (R-WY). [Vlog] Important Updates Regarding NIPPV NCD thumbnail [Vlog] Important Updates Regarding NIPPV NCD Watch below an important update from Ronda Burhmester, Sr. Director Payer Relations & Reimbursement, VGM & Associates, regarding non-invasive pressure ventilation. Make Your Voice Heard On The Competitive Bidding Program thumbnail Make Your Voice Heard On The Competitive Bidding Program “If the Competitive Bidding Program goes forward, it will be devastating—not just for providers like me but, most importantly, for the patients we serve,” said Jonathan Temple, owner of OxyMed LLC. You Got the Contract! Part 2: Maintaining It thumbnail You Got the Contract! Part 2: Maintaining It In our last article, we discussed the key provisions to be sure you know about your contract. It is critical to understand these provisions to help comply with the contract terms, fulfill your obligations as your business changes, and understand the payer's obligations and your rights under the contract. In this article we discuss some best practices for managing your contracts once you get them. Industry Uncertainty & Advocacy: What You Can Do Now thumbnail Industry Uncertainty & Advocacy: What You Can Do Now The proposed rule introduces broad structural changes without full clarity on implementation timelines or enforcement. Industry groups like VGM, AAHomecare, and CQRC are urging stakeholders to engage in advocacy to shape final rules. To prepare for the sweeping changes in the 2025 CMS Proposed Rule for DMEPOS, companies should take a multi-pronged strategic approach. Here is a breakdown of key preparation strategies: Alabama Durable Medical Equipment Association (ADMEA) Seeks New Executive Director thumbnail Alabama Durable Medical Equipment Association (ADMEA) Seeks New Executive Director The Alabama Durable Medical Equipment Association (ADMEA) is now accepting applications for the role of Executive Director. This is an exciting leadership opportunity for an individual with a passion for healthcare, industry advocacy, and association management. 2025 CMS Proposed Rule Challenges and To-Dos thumbnail 2025 CMS Proposed Rule Challenges and To-Dos The 2025 CMS Proposed Rule for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) introduces several significant changes that present both operational and financial challenges for DME companies.